Marker Therapeutics Cash Flow Statement (2015-2025) | MRKR

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Operating Activities
Net Income (Quarter)	-8.78M	-10.91M	-10.02M	-9.76M	-9.79M	-4.01M	-1.19M	-0.81M	-0.74M	6.61M	-8.79M	8.73M	-2.39M	-2.19M	-2.31M	5.09M	-4.45M	-4.13M	-2.00M	8.61M
Depreciation and Depletion (Quarter)	0.50M	0.50M	0.60M	0.50M	0.60M	0.60M	0.80M	-1.40M	0.80M
Share-based Compensation (Quarter)	1.38M	1.65M	1.47M	1.47M	1.63M	1.50M	1.50M	-1.32M	0.66M	0.61M	0.17M	0.87M	0.08M	0.06M	0.05M	0.05M	0.38M	0.01M	0.03M	0.11M
Cash from Discontinued Operations (Quarter)							-2.40M	-2.20M	-2.79M	-2.99M	-0.26M	-0.06M
Gains from Investment Securities (Quarter)	0.03M	7.46M	7.54M		0.02M	0.16M	2.53M	0.89M	0.00M	0.29M	0.61M	0.74M	0.08M	0.11M	0.60M	0.59M	0.73M	0.02M	0.03M	0.03M
Non-cash Items (Quarter)	0.33M	3.40M	3.81M	4.30M	4.80M	5.34M	5.88M	0.56M	0.60M	0.46M	1.02M	1.32M	0.72M	1.19M	0.39M	0.38M	0.41M	0.01M	0.44M	0.46M
Change in Interest Receivables (Quarter)	308.00	-1.00M	-43.00	-6.00	0.00M	0.63M	1.05M	0.72M	-1.32M	0.66M	-1.66M	0.94M	0.82M	0.64M	-1.75M	1.60M	0.11M	-0.78M	-0.01M
Cash from Operations (Quarter)	-8.10M	-6.79M	-7.54M	-4.86M	-12.23M	0.06M	-5.25M	-4.10M	-5.89M	-1.28M	-6.90M	-2.37M	-3.84M	-3.57M	1.20M	-4.70M	-5.50M	-1.88M	-2.74M	-1.90M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	0.25M	0.25M	0.25M	0.26M	0.26M	0.26M	0.22M	0.15M	0.15M
Amortization of Deferred Charges (Quarter)
Depreciation & Amortization (CF) (Quarter)	0.50M	0.53M	0.55M	0.56M	0.58M	0.58M	0.82M	0.81M	0.82M
Change in Working Capital
Change in Account Payables (Quarter)
Change in Accured Expenses (Quarter)	-1.48M	1.48M	2.74M	1.40M	-3.95M	2.89M	0.77M	-1.03M	0.11M	0.09M	-0.36M	1.49M	-0.98M	0.91M	0.88M	-0.43M	-1.30M	1.81M	-1.90M	-0.33M
Investing Activities
Capital Expenditures (Quarter)	0.22M	-0.06M	-0.09M	2.09M	2.33M	-2.31M	0.07M	-0.02M	0.14M
Divestments (Quarter)							-0.10M	-0.13M	-0.11M	18.78M
Cash from Investing Activities (Quarter)	-1.40M	-0.40M	-0.98M	-0.35M	-2.45M	-2.27M	-0.10M	-0.13M	-0.11M	18.78M
Financing Activities
Other financing activities (Quarter)	1.38M	1.65M	1.47M	1.47M	1.63M	1.50M	1.50M	0.72M	0.66M	0.60M	0.18M	0.14M	0.08M	0.06M	0.05M	0.05M	0.38M	0.01M	0.03M	0.11M
Debt Issuance and Repayment
Short-Term Debt issuances (Quarter)
Change in Capital Stock
Shares Issued (Quarter)	52.66M	-0.10M	-52.55M			0.06M		0.14M	0.62M	-0.62M	0.08M	0.01M	0.05M	0.04M	0.02M	0.00M	505.00	100.00	9.86M	-9.86M
Shares Repurchased (Quarter)
Misc.
Cash from Financing Activities (Quarter)	52.66M	-0.10M				0.06M		0.14M	0.62M	736.00	0.48M	0.01M	0.05M	0.04M	0.00M	14.90M	505.00	100.00	9.86M
Change in Cash (Quarter)	43.16M	-7.29M	-8.52M	-5.21M	-14.68M	-3.00M	-7.75M	-6.29M	-5.38M	11.72M	-0.65M	-2.36M	-3.79M	-3.52M	1.20M	10.19M	-5.50M	-1.88M	7.13M	-1.90M
Free Cash Flow (Quarter)	-8.32M	-6.73M	-7.45M	-6.95M	-14.55M	2.37M	-5.31M	-4.08M	-6.03M	-1.28M	-6.90M	-2.37M	-3.84M	-3.57M	1.20M	-4.70M	-5.50M	-1.88M	-2.74M	-1.90M
Net Cash Flow (Quarter)	43.16M	-7.29M	-8.52M	-5.21M	-14.68M	-2.14M	-5.35M	-4.09M	-5.38M	17.50M	-6.42M	-2.36M	-3.79M	-3.52M	1.20M	10.19M	-5.50M	-1.88M	7.13M	-1.90M

Research Tools

Marker Therapeutics Cash Flow Statement (2015-2025) | MRKR

Create an account

Sign In

Reset Password